News by Subject Medicine & Health

In an ATS 2017 International Conference first, respiratory health professionals and patients joined other conference attendees at a rally near the Capitol on Tuesday, May 23 to voice their concerns about recent policies that threaten to undermine many of the ATS's advocacy priorities including: research funding, tobacco regulation, affordable health care, and clean air. Also participating in the rally was US senators Edward Markey (D-MA) and Tom Carper (D-DE).

In a new study presented at the 2017 American Thoracic Society International Conference, adult asthma patients treated with bronchial thermoplasty (BT) had fewer severe exacerbations and were able to reduce their ER visits and hospitalizations in the two years following treatment.

Directly injecting a tumor with an agent that activates a natural, powerful tumor suppressor enhances the drug's capacity to attack the tumor both locally and where it spreads, scientists report in the journal Cancer Research.

Immune diseases like multiple sclerosis and hemophagocytic lymphohistiocytosis unleash destructive waves of inflammation on the body, causing death or a lifetime of illness and physical impairment. With safe and effective treatments in short supply, scientists report in PNAS Early Edition discovery of an experimental treatment that targets an Achilles heel of activated immune cells -- killing them off and stopping autoimmune damage.

Rutgers University-New Brunswick scientists have created a graphene-based sensor that could lead to earlier detection of looming asthma attacks and improve the management of asthma and other respiratory diseases, preventing hospitalizations and deaths.